Regional dissemination of vancomycin-resistant enterococci resulting from interfacility transfer of colonized patients

Journal of Infectious Diseases

Volumn 180, Issue 2, 1999, Pages 391-396

  Trick, William E ^a   Kuehnert, Matthew J ^a   Quirk, Stephen B ^b   Arduino, Matthew J ^a   Aguero, Sonia M ^a   Carson, Loretta A ^a   Hill, Bertha C ^a   Banerjee, Shailen N ^a   Jarvis, William R ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Siouxland District Health Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE TRANSMISSION; ENTEROCOCCUS FAECIUM; FEMALE; GASTROINTESTINAL INFECTION; HEALTH CARE FACILITY; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT TRANSPORT; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE FACILITIES; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CROSS INFECTION; DIGESTIVE SYSTEM; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS, COMMUNITY; HUMANS; IOWA; MALE; MIDDLE AGED; PATIENT TRANSFER; PREVALENCE; VANCOMYCIN;

EID: 0033495329     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314898     Document Type: Article

References (21)

1. 1. Weinstein JW, Roe M, Towns M, et al. Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital. Infect Control Hosp Epidemiol 1996;17:36-41.
2. 2. Morris JG Jr, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med 1995;123:250-9.
3. 3. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126-33.
4. 4. Bonilla HF, Zervos MA, Lyons MJ, et al. Colonization with vancomycin-resistant Enterococcus faecium: comparison of a long-term care unit with an acute-care hospital. Infect Control Hosp Epidemiol 1997;18:333-9.
5. 5. Dembry LM, Uzokwe K, Zervos MJ. Control of endemic glycopeptide-resistant enterococci. Infect Control Hosp Epidemiol 1996;17:286-92.
6. 6. Montecalvo M, Shay DK, Andryshak C, et al. Efficacy of enhanced infection control measures to reduce the transmission of vancomycin-resistant enterococci (VRE) [abstract J39]. In: Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1995;264.
7. 7. Jochimsen EM, Fish L, Manning K, et al. Control of vancomycin-resistant enterococci at a community hospital: efficacy of patient and staff cohorting. Infect Control Hosp Epidemiol 1999;20:106-9.
8. 8. Chow JW, Kuritza A, Shlaes DM, Green M, Sahm DF, Zervos MJ. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J Clin Microbiol 1993;31:1609-11.
9. 9. Weinstein JW, Tallapragada S, Dembry LM. Comparison of rectal and perirectal swabs for detection of colonization with vancomycin-resistant enterococci. J Clin Microbiol 1996;34:210-2.
10. 10. Buescher J, Chen CM, Edberg SC, Sewell D, Van Horn K. Multicenter evaluation of a new method for vancomycin resistant enterococci detection directly from VRE surveillance specimens [abstract C-4]. In: 97th general meeting of the American Society for Microbiology (Miami Beach). Washington, DC: ASM, 1997;121.
11. 11. Chen CM, Doherty K, Dichter G, Naqui A. VRE Select™: Rapid detection of VRE directly from surveillance specimens [abstract C-6]. In: 97th General Meeting of the American Society for Microbiology (Miami Beach). Washington, DC: ASM, 1997;122.
12. 12. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically fourth edition. Approved Standard M7-A4. 17th ed. Villanova, Pa: NCCLS, 1997.
13. 13. Bonten MJ, Haydeen MK, Nathan C, et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 1996;348:1615-9.
14. 14. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995;172:993-1000.
15. 15. Dean AG, Dean JA, Coulombier D, et al. Epi Info, version 6.03: a word processing database and statistics program for epidemiology on microcomputers. Atlanta: Centers for Disease Control and Prevention, 1995.
16. 16. SAS Institute. SAS procedures guide, version 6. 3rd ed. Cary, NC: SAS Institute, 1990.
17. 17. Quale J, Landman D, Saurina G, Atwood E, DiTore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996;23:1020-5.
18. 18. Lam S, Singer C, Tucci V, Morthland VH, Pfaller MA, Isenberg HD. The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study. Am J Infect Control 1995;23:170-80.
19. 19. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance, recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 1995;44:1-13.
20. 20. Pegues DA, Pegues CF, Hibberd PL, Ford DS, Hooper DC. Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital. J Clin Microbiol 1997;35: 1565-70.
21. 21. Rosenberg J, Vugia DJ, Jarvis W. Surveillance for vancomycin-resistant enterococci (VRE), San Francisco Bay Area, 1993 1996 [abstract 726]. In: Program and abstracts of the 35th annual meeting of the Infectious Diseases Society of America (San Francisco). Washington, DC: American Society for Microbiology, 1997;206.